291011BS2 Financials

Please note, the presentation of 291011BS2's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, 291011BS2's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of 291011BS2's management manipulating its earnings.

291011BS2's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. 291011BS2 volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.

The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on EMR 28 21 correlated with the market. If Beta is less than 0 291011BS2 generally moves in the opposite direction as compared to the market. If 291011BS2 Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one EMR 28 21 is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of 291011BS2 is generally in the same direction as the market. If Beta > 1 291011BS2 moves generally in the same direction as, but more than the movement of the benchmark.